Yonsei Med J.  2008 Jun;49(3):496-499. 10.3349/ymj.2008.49.3.496.

A Case of Ischemic Colitis Associated with the Herbal Food Supplement Ma Huang

Affiliations
  • 1Department of Internal Medicine, Ewha Medical Research Institute, Ewha Womans University School of Medicine, Seoul, Korea. shimkn@ewha.ac.kr

Abstract

Ischemic colitis is a condition that usually occurs in the elderly, as a form of vascular disease. However, ischemic colitis also occurs, though rarely, in healthy young adults. Moreover, food supplements containing Ephedra sinica or ma huang have been linked to adverse central nervous and cardiovascular events. A 40-year-old man was admitted to our emergency department after 2 episodes of abdominal pain and bloody diarrhea that lasted 24 hours. His medical history was unremarkable for risk factors of bowel ischemia, except for well-controlled hypertension. However, a weight-loss supplement, Ephedra sinica, had been prescribed for daily use during the previous month. Both abdominal/pelvic computed tomography and colonoscopy revealed findings compatible with ischemic colitis. His conditions spontaneously improved without any serious complications, and he was advised to discontinue the use of herbal medications containing ephedrine. In this paper, we describe a case of ischemic colitis that was potentially linked to the use of ma huang with a review of the relevant literature.

Keyword

Ischemic colitis; ephedra sinica; ma huang

MeSH Terms

Abdominal Pain/etiology
Adult
Colitis, Ischemic/*diagnosis/etiology
Diarrhea/etiology
*Dietary Supplements
Drugs, Chinese Herbal/administration & dosage/adverse effects
Ephedra sinica/*chemistry
Humans
Male

Figure

  • Fig. 1 Abdominal and pelvic CT scans show a patent superior mesenteric artery (A) and edematous circumferential wall thickening of the ascending, transverse, and descending colon (B).

  • Fig. 2 (A) Colonoscopy on admission show hemorrhagic friable mucosal patches with mucosal edema from the ascending to the descending colon. (B) Colonoscopy at an 8-day follow-up show marked mucosal improvement.

  • Fig. 3 Colonoscopic biopsy specimen from the transverse colon show focal mucosal erosion and chronic inflammatory cell infiltration (H&E stain, × 200).


Reference

1. Sreenarasimhaiah J. Diagnosis and management of intestinal ischaemic disorders. BMJ. 2003. 326:1372–1376.
Article
2. MacDonald PH. Ischaemic colitis. Best Pract Res Clin Gastroenterol. 2002. 16:51–61.
Article
3. Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: systematic review. Obes Rev. 2005. 6:93–111.
Article
4. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000. 343:1833–1838.
Article
5. Ryan CK, Reamy B, Rochester JA. Ischemic colitis associated with herbal product use in a young woman. J Am Board Fam Pract. 2002. 15:309–312.
6. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003. 289:1537–1545.
Article
7. Krome CN, Tucker AM. Cardiac arrhythmia in a professional football player: Was ephedrine to blame? Phys Sportsmed. 2003. 31:21–25. 29
8. Rezkalla SH, Mesa J, Sharma P, Kloner RA. Myocardial infarction temporally related to ephedra-a possible role for the coronary microcirculation. WMJ. 2002. 101:64–66.
9. Naik SD, Freudenberger RS. Ephedra-associated cardiomyopathy. Ann Pharmacother. 2004. 38:400–403.
Article
10. Chen C, Biller J, Willing SJ, Lopez AM. Ischemic stroke after using over the counter products containing ephedra. J Neurol Sci. 2004. 217:55–60.
Article
11. Charatan F. Ephedra supplement may have contributed to sportsman's death. BMJ. 2003. 326:464.
Article
12. Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults. Int J Obes Relat Metab Disord. 2002. 26:1363–1366.
Article
13. Haller CA, Jacob P 3rd, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther. 2002. 71:421–432.
Article
14. McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA. 2004. 291:216–221.
Article
15. Jellin JM, Gregory P, Batz F, Hitchens K, editors. Ephedra. Natural medicines comprehensive database. 2000. 3rd ed. Stockton, CA: Therapeutic Research Faculty;400–403.
16. Lichtenstein GR, Yee NS. Ischemic colitis associated with decongestant use. Ann Intern Med. 2000. 132:682.
Article
17. Dowd J, Bailey D, Moussa K, Nair S, Doyle R, Culpepper-Morgan JA. Ischemic colitis associated with pseudoephedrine: four cases. Am J Gastroenterol. 1999. 94:2430–2434.
Article
18. Comay D, Ramsay J, Irvine EJ. Ischemic colitis after weight-loss medication. Can J Gastroenterol. 2003. 17:719–721.
Article
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr